What are GLP-1 receptor agonists
This has the potential to help the body utilize nutrients effectively and could bolster the efficacy of treatment
Marcus NY, Blomenkamp K, Ahmad M, Teckman JH
Moreover, improving our metabolic rate can significantly impact our appetite
For many individuals, these effects attenuate over time as physiological adaptation occurs, though some patients continue to experience persistent symptoms throughout treatment
Carmot is currently conducting a multi-center, randomized, placebo-controlled Phase 2 clinical trial of CT-868 in participants with overweight/obesity and T1D to assess efficacy, safety, tolerability, and pharmacokinetics